Screening Technology Company IntelliCyt Raises $8M | GenomeWeb

NEW YORK (GenomeWeb News) – Screening technology firm IntelliCyt today said it raised $8 million in a financing round.

New investor Arboretum Ventures led the financing and was joined by existing investors Prolog Ventures, Verge Fund, and New Mexico Community Capital.

Tim Petersen and George Dunbar from Arboretum Ventures are joining IntelliCyt's board in connection to the financing, the Albuquerque, NM-based company said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: experts say race is not a sufficient proxy for studying human genetic diversity and more.

Technology Review writes that CRISPR/Cas9 gene editing firm Editas' success may hinge on a patent case.

Researchers unearthed a bioinformatics error in the Science paper reporting the first ancient African genome, and the authors are seeking an erratum.

A boy's cystic fibrosis carrier status was revealed by a teacher to the parents of children with CF who then sought the boy's transfer to another school, leading to a lawsuit.